{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:46:22Z","timestamp":1759776382279,"version":"3.44.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.kint.2017.09.024","type":"journal-article","created":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T00:58:03Z","timestamp":1516323483000},"page":"310-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Levamisole in relapsing steroid-sensitive nephrotic syndrome: where do we stand?"],"prefix":"10.1016","volume":"93","author":[{"given":"Markus J.","family":"Kemper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2017.09.024_bib1","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00467-010-1717-5","article-title":"New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome","volume":"26","author":"van Husen","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2017.09.024_bib2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0022-3476(80)80707-4","article-title":"Treatment of nephrotic syndrome with levamisole","volume":"96","author":"Tanphaichitr","year":"1980","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.kint.2017.09.024_bib3","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/0140-6736(91)93257-A","article-title":"Levamisole for corticosteroid-dependent nephrotic syndrome","volume":"337","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2017.09.024_bib4","first-page":"CD002290","article-title":"Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children","volume":"10","author":"Pravitsitthikul","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.kint.2017.09.024_bib5","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.kint.2017.08.011","article-title":"A\u00a0randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome","volume":"93","author":"Gruppen","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.09.024_bib6","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00467-017-3616-5","article-title":"Efficacy of higher-dose levamisole in maintaining remission in steroid-dependent nephrotic syndrome","volume":"32","author":"Abeyagunawardena","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2017.09.024_bib7","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1681\/ASN.2012121200","article-title":"Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome","volume":"24","author":"Gellermann","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.09.024_bib8","doi-asserted-by":"crossref","unstructured":"Iijima K, Sako M, Kamei K, Nozu K. Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials [e-pub ahead of print]. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-017-3746-9. Accessed October 28,\u00a02017.","DOI":"10.1007\/s00467-017-3746-9"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253817307743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253817307743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:49:03Z","timestamp":1758761343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253817307743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0085253817307743"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2017.09.024","relation":{},"ISSN":["0085-2538"],"issn-type":[{"type":"print","value":"0085-2538"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levamisole in relapsing steroid-sensitive nephrotic syndrome: where do we stand?","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2017.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2017.08.011","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}